Next Article in Journal
Evaluation of the In Vitro Antifungal Activity of Novel Arylsulfonamides against Candida spp.
Previous Article in Journal
Bacterial Diversity Analysis and Screening for ACC Deaminase-Producing Strains in Moss-Covered Soil at Different Altitudes in Tianshan Mountains—A Case Study of Glacier No. 1
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Detection of Antagonistic Compounds Synthesized by Bacillus velezensis against Xanthomonas citri subsp. citri by Metabolome and RNA Sequencing

by
Muhammad Fazle Rabbee
and
Kwang-Hyun Baek
*
Department of Biotechnology, Yeungnam University, Gyeongsan 38541, Republic of Korea
*
Author to whom correspondence should be addressed.
Microorganisms 2023, 11(6), 1523; https://doi.org/10.3390/microorganisms11061523
Submission received: 29 March 2023 / Revised: 17 May 2023 / Accepted: 4 June 2023 / Published: 8 June 2023
(This article belongs to the Section Plant Microbe Interactions)

Abstract

:
Biological control of plant diseases has gained attraction for controlling various bacterial diseases at a field trial stage. An isolated endophytic bacterium, Bacillus velezensis 25 (Bv-25), from Citrus species had strong antagonistic activity against Xanthomonas citri subsp. citri (Xcc), which causes citrus canker disease. When Bv-25 was incubated in Landy broth or yeast nutrient broth (YNB), the ethyl acetate extract of Landy broth exhibited higher levels of antagonistic activity against Xcc compared to that of YNB. Therefore, the antimicrobial compounds in the two ethyl acetate extracts were detected by high performance liquid chromatography–mass spectrometry. This comparison revealed an increase in production of several antimicrobial compounds, including difficidin, surfactin, fengycin, and Iturin-A or bacillomycin-D by incubation in Landy broth. RNA sequencing for the Bv-25 grown in Landy broth were performed, and the differential expressions were detected for the genes encoding the enzymes for the synthesis of antimicrobial compounds, such as bacilysin, plipastatin or fengycin, surfactin, and mycosubtilin. Combination of metabolomics analysis and RNA sequencing strongly suggests that several antagonistic compounds, especially bacilysin produced by B. velezensis, exhibit an antagonistic effect against Xcc.

1. Introduction

Phytopathogenic bacteria cause numerous plant diseases worldwide, resulting in considerable losses in crop production and storage [1]. The control strategies for these diseases pose one of the greatest challenges to sustainable agriculture. Due to the difficulty of managing bacterial diseases naturally, growers heavily rely on chemical agents, especially pesticides [2]. Extensive and repeated applications of these chemicals have led to the development of pesticide resistance in the target phytopathogens and even non-target organisms, including human beings [2]. Besides chemical pesticides, the public is becoming more concerned about using antibiotics in the environment due to their adverse effects on human health and are suspicious of the massive application of antibiotics due to the advent of antibacterial resistance [3]. Therefore, in recent years, biological control agents (i.e., specialized microbes or its metabolite to control plant diseases) are gaining attention from scientists and farmers as an alternative mean of plant disease management. Until now, numerous biocontrol agents have been commercially available to control plant diseases [4].
Citrus canker is a devastating disease caused by the bacterial pathogen Xanthomonas citri subsp. citri (Xcc), which affects most commercial citrus varieties. Infection of Xcc causes necrotic lesions on citrus leaves, stems, and fruits, resulting in premature fruit loss, defoliation, twig dieback, and tree decline [5]. The disease impacts fruit production detrimentally by both decreasing fruit yields in most citrus-producing countries and making the infected fruits less valuable and unmarketable [6]. The most common approach to control citrus canker is the usage of copper-based bactericidal sprays such as copper hydroxide, cuprous oxide, and copper oxychloride [7]. Copper-resistant strains, however, have been detected on several phytopathogenic bacteria, including Xcc, X. axonopodis pv. vesicatoria, X. alfalfae subsp. citrumelonis, and Pseudomonas syringae pv. tomato [7,8]. A copper-resistant strain of Xcc was first reported in 1994 in the province of Corrientes, Argentina, where the citrus nurseries were exposed to regular application of copper-based bactericides [8]. The antibiotic streptomycin is extensively used to control Xcc; however, streptomycin resistance emerges several- or thousand-folds due to chromosomal or gene mutations [9]. Streptomycin resistance exhibits an increasing pattern due to the repeated usage of the chemical. For example, in the case of pathogenic X. perforans, resistance increased from 5% in 2006 to 14% in 2011 during field applications of streptomycin [10].
Plant pathologists and microbiologists, therefore, have developed novel strategies for developing biocontrol agents to control phytopathogenic bacteria in more cost-effective and environmentally friendly ways [11]. Numerous new microbes containing biologically active agents have been identified in an effort to reduce the excessive use of chemical pesticides in agriculture [12]. Among the commercially developed biocontrol agents, the most used organisms are based on the isolation of Bacillus spp. For example, Botrybel (B. velezensis), RhizoVital® (B. velezensis FZB42T), Serenade (B. velezensis QST713), Kodiak TM (B. velezensis GB03), and Taegro® (B. velezensis FZB24) [13]. Pseudomonas- and Strepotomyces-based biocontrol agents are also available in the market [12]. These biocontrol agents exhibit various modes of action, such as antimicrobial compound secretion, systemic resistance induction, and nutrient competition with the pathogenic microbes [11].
Next-generation genome sequencing has revealed that many biosynthetic gene clusters encode bioactive secondary metabolites in the genomes of several Bacillus species, e.g., B. velezensis, B. subtilis, B. amyloliquefaciens, and B. siamensis [14,15,16,17]. B. velezensis is an endospore-forming and free-living soil bacterium, first described by Ruiz-Garcia in 2005 [18]. The enzymes encoded by these biosynthetic genes synthesize antimicrobial compounds that could serve as a reservoir of novel scaffolds for drug screening to treat numerous plant diseases [19,20]. Following complete sequencing and annotation of the B. velezensis genome, considerable parts of the genomic DNA were found harboring various antimicrobial gene clusters. The clusters of srf, bmy, fen, mln, dfn, bae, dhb, and bac encode the active compounds surfactins, bacillomycin D, fengycins, macrolactin, difficidin, bacillaene, bacillibactin, and bacilysin, respectively [21]. These bioactive secondary metabolites have numerous applications in plant-microbe interactions with antimicrobial and nematocidal activities [21]. Among the compounds, surfactins, bacillomycin D, and fengycins are grouped as lipopeptides (LPs), and the classification of these compounds is based on the length variation of fatty acid chain and amino acid sequences of these compounds [22]. Macrolactin, difficidin, and bacillaene are classified as polyketide molecules (PKs) that are synthesized by giant modular polyketide synthases with multifunctional domains [23].
LPs are mainly associated with antifungal action, especially against filamentous fungi. For example, bacillomycin D synthesized by B. velezensis FZB42 exhibited strong antifungal action against Fusarium graminearum that causes Fusarium head blight [24]. Lipopeptide fengycins produced by B. velezensis Bs006 suppressed mycelial growth of F. oxysporum f. sp. physali that is responsible for golden berry wilt disease [25]. Surfactin B and surfactin C produced by B. velezensis 9D-6 exhibits antifungal activities against Monilinia fructicola that causes brown rot of nectarine and some other stone fruits [26]. Similarly, the antifungal activity of B. velezensis LM2303 was mainly associated with fengycin B, iturin A, and surfactin A [25]. Under field conditions, LM2303 exhibited strong antagonist activity against F. graminearum by significantly reducing disease severity of Fusarium head blight, with a control efficiency of 72.3% [27].
The antibacterial activity of B. velezensis is mainly associated with PKs including macrolactin, difficidin, and bacillaene [28]. For example, difficidin and bacilysin produced by B. velezensis FZB42 exhibited antibacterial activity against Xanthomonas oryzae pv. oryzae and X. oryzae pv. oryzicola [29]. B. velezensis LM2303 encodes several antibacterial compounds such as surfactin A, butirosin, plantazolicin, kijanimicin, bacilysin, difficidin, bacillaene, and macrolactin. In addition, other metabolites including iron–siderophore bacillibactin, molybdenum cofactor, and teichuronic acid were involved with nutrient uptake during plant–microbe interaction [27]. Moreover, the antifungal action of dipeptide antibiotic bacilysin was reported; for example, bacilysin produced by FZB42 damaged the hyphal structure of Phytophthora sojae that causes root rot disease in soybean [30]. Two other ribosomally synthesized bacteriocin, known as plantazolicin and amylocyclicin in B. velezensis, displayed high antibacterial activities against closely related Gram-positive bacteria [31,32]. Bacillibactin secreted by B. velezensis can bind with environmental iron to form siderophore–iron complex and can be internalized into the bacterium, where iron is released for cellular processes or nutritional requirements [33].
Previously, we isolated B. velezensis-25 (Bv-25), which exhibited antibacterial activity against wild-type and streptomycin-resistant Xcc strains [34,35]. Therefore, we conducted this research to further understand the antibacterial compounds produced by B. velezensis that can control citrus canker disease effectively and efficiently. Through the application of various state-of-the-art techniques, such as transcriptome analysis, high performance liquid chromatography–mass spectrometry (HPLC-MS) analysis, and antimicrobial assays, we identified the differentially expressed genes and antibacterial compounds, which may be involved in exerting the antagonistic effects on Xcc.

2. Materials and Methods

2.1. Strains and Culture Conditions

Bv-25 and B. amyloliquefaciens strain 2 (Ba-2) were incubated in yeast nutrient broth (YNB: yeast extract, 5 g; and nutrient broth, 8 g in 1 L distilled water) and in Landy broth (L-glutamic acid 5 g, glucose 20 g, yeast extract 1 g, phenylalanine 2 mg, MgSO4·7H2O 0.5 g, KCl 0.5 g, MnSO4 5 mg, CuSO4·5H2O 0.16 mg, FeSO4·7H2O 0.15 mg, KH2PO4 1 g in 1 L H2O, pH 7.0). Bv-25 was isolated from citrus species in our laboratory, and Ba-2 was provided by the Korean Agricultural Culture Collection (KACC, RDA, Wanju-gun, Republic of Korea). The pathogenic Xcc strains used for bioassay were composed of two Xcc strains, wild-type XccW1 and streptomycin-resistant mutant XccM4 [9]. The pathogenic Xcc strains were kind gifts from Dr. Hyun (Citrus Research Station, NIHH, RDA, Jeju, Republic of Korea). The wild-type and streptomycin-resistant strains of Xcc were routinely grown on yeast nutrient agar (YNA, yeast extract, 5 g; nutrient broth, 8 g; and agar, 1.5 g in distilled water, 1 L) or YNA supplemented with 50 ppm streptomycin, respectively. All the strains, such as Bv-25, Ba-2, and Xcc, were maintained in YNB containing 50% glycerol at −80 °C until use.

2.2. Antibacterial Activity of Ethyl Acetate Extracts of Bv-25 and Ba-2 in Landy Broth and YNB

To compare the production of active compounds in different media, 50 μL of B. velezensis Bv-25 and Ba-2 cells from the stock were added to 2 mL of different media including Landy broth and YNB. The cultures were then incubated for 24 h at 28 °C. The seed cultures (0.1 mL) of B. velezensis Bv-25 and Ba-2 were then transferred into 100 mL of Landy and YNB broth and cultured for 48 h at 28 °C in a shaking incubator with 180 rpm. The growth of bacterial cells in different media was monitored using OD600nm by a spectrophotometer (ASP-3700, ACTGene, Piscataway, NJ, USA). An equal volume of ethyl acetate (100 mL) was added to the bacterial cultures, sonicated for 5 min, and maintained overnight with vigorous shaking. The culture mixture was centrifuged at 3000 rpm for 10 min at 4 °C, the supernatants collected, and dried in a rotary evaporator (A-1000S; Eyela, Tokyo, Japan) at 50 °C.
The residues were dissolved In 1.5 mL HPLC-grade methanol and air-dried under a chemical hood. After drying, metabolites were weighed and the metabolite concentrations were prepared (10.0 mg mL−1, 1.0 mg mL−1 and 0.1 mg mL−1) using HPLC-grade methanol.
Disk-diffusion assays were used to test the antibacterial activity of ethyl acetate extracts against Xcc strains. XccW1 and XccM4 strain grown overnight was mixed with 5 mL of 0.7% YNA soft agar and directly poured onto 1.5% agar YNA plates. After gel solidification, 30 µL of the metabolites in three different concentrations, such as 10.0 mg mL−1, 1.0 mg mL−1, and 0.1 mg mL−1, were placed on a sterile paper disk. The antibacterial activity of the ethyl acetate extract was compared with the positive control composed of two streptomycin concentrations (S1: streptomycin 1.0 mg mL−1; S2: streptomycin 0.1 mg mL−1) and a negative control composed of 100% methanol. The inhibition zones after 24 h incubation at 28 °C around the paper disks were measured using an electronic digital caliper, and the antibacterial activities were compared. The experiment was conducted twice with three replicates.

2.3. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of Bv-25 and Ba-2 Extracts Cultured in Landy Broth and YNB

After selecting Landy medium as the highest antibacterial activity-inducing medium, MIC and MBC of ethyl acetate extracts of Bv-25, Ba-2, and streptomycin were determined using Landy broth and YNB by the broth microdilution method [36]. The metabolite was collected from the bacterial culture, weighed and dissolved in methanol at a concentration of 2.0 gm mL−1 (stock solution). For MIC analysis, the metabolites of Bv-25 and Ba-2 were two-fold serially diluted using methanol in order to make concentrations ranging from 15.625–1000 μg mL−1. The study of MIC was conducted in 96-well plates. Each well contained a total 200 µL, composed of 100 µL metabolites of Bv-25 and Ba-2, 90 µL broth, and 10 µL indicator bacterial inoculum with an optical density of 2.0 at 600 nm. One well served as a positive control (YNB plus inoculum), and one served as a negative control (only YNB). The plates were incubated at 28 °C for 24 h. MIC was defined as the lowest concentration of metabolite extract that prevented the visible growth of the indicator bacterial strain. Additionally, MBC was determined by plating 10 µL of the cultures from each well in YNA agar plates. MBC was defined as the lowest concentration of metabolite extract that did not show any bacterial growth in YNA plates after an incubation period of 24 h at 28 °C. Both the MIC and MBC were expressed in µg mL−1.

2.4. HPLC-MS Analysis of Ethyl Acetate Extracts from Bv-25 and Ba-2

The ethyl acetate extracts of Bacillus spp. were filtered by using 0.22 µm nylon filter that was then analyzed by using liquid chromatograph–mass spectrometry (HPLC-MS). The HPLC-MS system was composed of an HPLC apparatus (model 2695; Waters, Milford, MA, USA) equipped with a pentafluorophenyl column (Luna C18 reversed phase column, 4.6 × 150 mm, 5μm; Phenomenex, Torrance, CA, USA) and a mass spectrometer (Waters model 3100, Milford, MA, USA). The HPLC conditions were as follows: injection volume = 5 µL, solvent A = 20 mM Ammonium acetate buffer (pH adjusted to 7.2), solvent B = acetonitrile, and solvent program = 50: 50 (A/B) to 50: 50 (A/B) over 10 min at a flow rate of 0.5 mL/min. MS data was obtained under the following conditions: desolvation gas (N2) flow rate = 4 L/h, desolvation temperature = 350 °C, capillary voltage = 4 kV, cone voltage = 30 V, ionization mode = electrospray positive, and single ion recording m/z = 163.

2.5. Differential Gene Expression Analysis of Bv-25 Grown in Landy Broth and YNB

RNA-sequence analysis was employed to disclose the transcriptomic features of Bv-25 genes that were expressed in two different media (Landy and YNB). In this process, genetic information from a gene is translated in the synthesis of a functional gene product, typically proteins. Total RNA was purified from Bv-25 and propagated for 24 h using Landy broth and YNB. Bacteria were collected by centrifugation at 8000 rpm at 4 °C for 10 min, and the cell pellets (bacterial cells) were then immediately frozen in liquid nitrogen and stored at −80 °C until use. RNA extraction (performed with the RNeasy Midi kit; Qiagen, Hilden, Germany), RNA quantification, and cDNA synthesis and labeling were performed as described previously [37]. Log2 fold change (log2 FC) was calculated through dividing FPKM (Fragments per kilobase of exon model per million mapped reads) value of Bv-25 grown in Landy by Bv-25 grown on YNB to obtain fold change (FC) and then putting the equation in excel as Log(FC, 2).

2.6. Antibacterial Activity Assay of Pure Surfactin and Fengycin against Xcc

Several antibacterial compounds were detected by metabolome and transcriptome analysis. Several compounds such as fengycin and surfactin (purchased from Sigma-Aldrich, St. Louis, MO, USA) and macrolactin isolated from Bv-25 (purified and identified by Dr. Sanghee Shim from Seoul National University, Seoul, Republic of Korea) were tested for antagonistic effects against Xcc based on the procedure described in Section 2.2.

3. Results

3.1. Antibacterial Activity of Ethyl Acetate Extracts of Bv-25 in Landy and YNB

In the disk diffusion assays, ethyl acetate extracts of Bv-25 were screened for their antibacterial potentiality against the wild-type XccW1 and streptomycin resistant XccM4 strains (Figure 1). The metabolite extracted from Bv-25 using Landy broth showed higher antibacterial activity against both Xanthomonas strains than the one extracted using YNB. At a concentration of 10.0 mg mL−1 (extracted from Landy broth), the zones of inhibition for Bv-25 metabolites against XccW1 and XccM4 were 26.59 ± 1.29 mm and 30.97 ± 2.3 mm, respectively. At a concentration of 1.0 mg mL−1, these metabolites inhibited XccW1 and XccM4 with zones of inhibition of 17.75 ± 0.91 mm and 20.81 ± 0.78 mm, respectively. On the other hand, the metabolites that was isolated from Bv-25 using YNB broth displayed a substantially reduced zone of inhibition in comparison to the Landy broth extracted metabolites. The zones of inhibition against XccW1 and XccM4 at a dose of 10 mg mL−1 were 22.83 ± 0.53 and 22.43 ± 1.53 mm, respectively. For the same metabolites at a dose of 1 mg mL−1, the zones of inhibition against XccW1 and XccM4 were 12.91 ± 0.37 and 12.84 ± 0.55 mm, respectively. The metabolites extracted from Ba-2 did not exhibit any antibacterial effect against Xanthomonas pathogens.
Streptomycin concentration S1 and S2 had antagonistic effects on the wild-type XccW1, with the zone of inhibition 30.68 ± 2.12 mm and 19.26 ± 0.46 mm, respectively. However, S1 and S2 did not exhibit any antibacterial effect on the streptomycin-resistant XccM4 strain (Figure 1).

3.2. Determination of MIC and MBC of the Ethyl Acetate Extracts of Bv-25 and Ba-2 Incubated in Landy Broth and YNB

MIC and MBC of crude ethyl acetate extract of strain Bv-25 were determined by testing against two Xanthomonas pathogens, XccW1 and XccM4, using the broth micro-dilution method. For Bv-25 extract using Landy broth culture, the MIC and MBC were 31.25 µg mL−1 and 62.5 µg mL−1, respectively against two Xcc strains. On the other hand, MIC and MBC of Bv-25 metabolites using YNB culture was 62.5 µg mL−1 and 125.0 µg mL−1, respectively. MIC and MBC of streptomycin (control antibiotic) against XccW1 ranged from 1.25–2.5 µg mL−1, but MIC and MBC of streptomycin against the streptomycin-resistant XccM4 strains were significantly high and ranged from >500–1000 µg mL−1 (Table 1). Metabolite extracted from Ba-2 had no effect on any Xanthomonas strains.

3.3. Detection of Antimicrobial Compounds by HPLC-MS Analysis

HPLC-MS analysis was performed to identify the differentially produced molecules, based on the molecular weight from the MS database (Mass Spectrometry Data Center, NIST, Gaithersburg, MD, USA). These compounds mostly belonged to the class of LPs (iturin, fengycin, bacillomycin-D, and surfactin) and PKs (oxydifficidin, macrolactin, and bacillaene) (Table 2). HPLC-MS analyses indicated the presence of several active substances with protonated molecular ions at m/z 1036.6, corresponding to surfactin isoforms. The molecular mass of bacillomycin-D in the range m/z 1008–1036 matched with the molecular database. Notably, these results corresponded to the MS data obtained from the previous reports [29].

3.4. Differential Gene Expression Analysis of Bv-25 Grown in Landy and YNB Media

To reveal the transcriptomic correlates of overproduction, we performed transcriptome profiling via RNA-sequencing of Bv-25 in Landy broth and YNB with an incubation period of 3 days at 28 °C. Although most genes were medially expressed in both Landy and YNB throughout the cultivation period, genes were expressed at a higher level in Landy broth. A total of 3930 genes were expressed during the mRNA expression analysis. Based on the expression data, genes encoding bacilysin (bac), plipastatin (pps) or fengycin (fen), surfactin (srf), and mycosubtilin (myc) were increased based on fragments per kilobase of exon model per million mapped reads (FPKM) value (Figure 2, Table 3). Besides a substantial number of genes or gene clusters involved in rhizosphere adaptation in plant beneficial traits through the formation of biofilm or by assimilating nitrogen, iron (through secretion of siderophore bacillibactin), potassium, manganese (Mn2+), and magnesium (Mg2+). Numerous genes related to plant growth promotion and induction of systemic resistance in plants were found to be expressed during mRNA expression study and are summarized in Table 4 and Table 5.

3.5. Antibacterial Activity Assay of Pure Surfactin and Fengycin against Xcc

By analyzing the metabolome of Bv-25, several antimicrobial substances, including surfactin, fengycin or plipastatin, and macrolactin, were detected. Therefore, we checked the antibacterial activity of fengycin, surfactin, and macrolactin; however, we were unable to detect any antibacterial impact of these compounds against the Xanthomonas spp. (XccW1 and XccM4).

4. Discussion

Biological control of diseases by Bacillus spp. have been extensively used to combat plant pathogenic microbes due to their specific characteristics of heat and desiccation resistance that help in the formulation of stable and dry powder with longer shelf lives. Furthermore, Bacillus spp. are less toxic to the environment, are capable of producing antibiotics, spores, and biofilm, and induce systemic resistance in plants [38]. Metabolite produced by a particular microorganism is crucial in determining its efficacy to be a potential biocontrol agent to combat plant diseases. In this study, we showed that the ethyl acetate extracts of Bv-25 exhibited strong antibacterial activity against both wild type and streptomycin resistant Xcc. Furthermore, metabolite extracted from Landy broth incubation exerted stronger antibacterial activity than that extracted from YNB incubation.
HPLC-MS data obtained during this study showed that the antagonistic isolates were able to produce a variety of LPs (i.e., surfactins, bacilliomycin-D, and fengycin) and PKs type molecules (i.e., difficidin, bacillaene, and macrolactin). The result of this study also agree with previous investigations, which reported the presence of several non-ribosomally synthesized LPs- and PKs-type molecules in B. velezensis that showed antibacterial activity against phytopathogenic microbes [39]. These compounds have been investigated for their antagonistic effects against a wide variety of phytopathogenic microorganisms including Xanthomonas oryzae pv. oryzae and X. oryzae pv. oryzicola (bacterial blight and bacterial leaf streak disease of rice, respectively) [29], Rhizoctonia solani (bottom rot of lettuce) [40], and X. campestris pv. cucurbitae (bacterial leaf spot of cucurbits) [41]. Co-culture of B. velezensis FZB42 and pathogenic strain of X. campestris pv. campestris had antagonistic effect on the pathogen that causes black rot disease on cruciferous vegetables [42].
Transcriptome analysis of Bv-25 revealed the differentially increased expression of several gene clusters encoding bacilysin (bac), plipastatin (pps) or fengycin (fen), surfactin (srf), and mycosubtilin (myc) in the Landy broth incubation in comparison to YNB incubation. Bacilysin produced by B. velezensis is a dipeptide antibiotic, which relies on peptide transporters for uptake into the target cells and causes changes in the cell wall structure and efflux of intracellular components of X. oryzae pv. oryzae and X. oryzae pv. oryzicola after 12 h of exposure [29]. This dipeptide antibiotic also reported to show antifungal activity against Candida albicans. Upon the transportation of bacilysin into the C. albicans cells, intracellular proteinase hydrolyzes bacilysin into anticapsin and L-alanine. Anticapsin interacts with glucosamne-6-phosphate synthase of C. albicans, which is essential for cell wall formation [13,43].
Plipastatin or fengycin, a well-studied lipopeptide at a genetic level, is known to develop antifungal activity against filamentous fungi. Plipastatin A, secreted by B. amyloliquefaciens S76-3, displayed strong fungicidal activity against Fusarium graminearum by completely killing the conidial spores at the MIC range of 100 µg mL−1. Microscopy analyses revealed severe morphological changes in conidia and substantial distortions in F. graminearum hyphae and caused vacuolation [44]. Mycosubtilin is a potent LP-type antifungal peptide compound, mainly detected in B. subtilis. This compound is characterized by a β-amino fatty acid moiety linked to the circular heptapeptide [45]. Surfactins produced by B. subtilis 9407, which includes C13- to C16-surfactin A, were the primary antibacterial compound against Acidovorax citrulli (syn. Acidovorax avenae subsp. citrulli), which cause bacterial fruit blotch of cucurbit crops. A srfAB deletion mutant strain of B. subtilis 9407 ∆srfAB, was unable to synthesize surfactin as well as showed reduced ability to form biofilms, swarming motility and root colonization during in vivo experiments [46].
Based on the metabolome and transcriptome analysis, we prepared the commercially available pure fengycin and surfactin and an isolated compound macrolactin from Bv-25. We found the antagonistic effect against Xcc to be non-existent, therefore, there are only few B. velezensis-producing compounds left, including bacilysin, difficidin, bacillaene, bacillomycin D, and iturin. We assumed that the most promising candidate could be bacilysin because the activity of ethyl acetate decreased after only one week, indicating the most active compound is unstable due to presence of epoxy group on bacilysin. The unstable nature of this compound can be the most difficult challenge for agricultural application. Collectively, this study indicates that B. velezensis could be a promising candidate to control citrus canker caused by X. citri subsp. citri and may provide an effective strategy to combat plant pathogens.

5. Conclusions

In this study, we investigated the antibacterial compounds synthesized by B. velezensis Bv-25 against the phytopathogenic Xcc. Our combined investigation by HPLC-MS and differential gene expression analysis identified several LPs and PKs type antimicrobial compounds, as well as a dipeptide antibiotic, bacilysin. We assumed that bacilysin produced by B. velezensis could be the controlling agent against Xcc. Though bacilysin has been identified as a strong antimicrobial agent, the epoxy group in the compound makes it unstable. In addition to the investigation of freshly prepared bacilysin for the antagonistic effect against Xcc, future work will focus on the stabilization of bacilysin activity by modifying the molecular structure to interfere with the spontaneous degradation of bacilysin.

Author Contributions

M.F.R. and K.-H.B. collected the data and wrote the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Cooperative Research Program for Agriculture Science and Technology Development (project No. PJ015726) and the Rural Development Administration (RDA), Republic of Korea.

Data Availability Statement

Not applicable.

Acknowledgments

We appreciate the funding from RDA (PJ015726), Republic of Korea.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mansfield, J.; Genin, S.; Magori, S.; Citovsky, V.; Sriariyanum, M.; Ronald, P.; Dow, M.; Verdier, V.; Beer, S.V.; Machado, M.A.; et al. Top 10 plant pathogenic bacteria in molecular plant pathology. Mol. Plant Pathol. 2012, 13, 614–629. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Hawkins, N.J.; Bass, C.; Dixon, A.; Neve, P. The evolutionary origins of pesticide resistance. Biol. Rev. 2019, 94, 135–155. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Symonds, N. Antibiotic resistance in bacteria. Postgrad. Med. J. 1972, 48, 216–221. [Google Scholar] [CrossRef] [Green Version]
  4. Collinge, D.B.; Funck, D.; Mojgan, J.; Sabrina, R.; Shaw, M.W.; Shaw, R.H. Biological control of plant diseases-What has been achieved and what is the direction? Plant Pathol. 2022, 71, 1024–1047. [Google Scholar] [CrossRef]
  5. Graham, J.H.; Leite, R.P.; Yonce, H.D.; Myers, A.M. Streptomycin controls citrus canker on sweet orange in Brazil and reduces risk of copper burn on grapefruit in Florida. Proc. Fla. State Hort. Soc. 2008, 121, 118–123. [Google Scholar]
  6. Gottwald, T.R. Analysis of foci of Asiatic citrus canker in a Florida citrus orchard. Plant Dis. 1992, 76, 389–396. [Google Scholar] [CrossRef]
  7. Marin, T.G.S.; Galvanin, A.L.; Lanza, F.E.; Behlau, F. Description of copper tolerant Xanthomonas citri subsp. citri and genotypic comparison with sensitive and resistant strains. Plant Pathol. 2019, 68, 1088–1098. [Google Scholar] [CrossRef]
  8. Behlau, F.; Canteros, B.I.; Minsavage, G.V.; Jones, J.B.; Graham, J.H. Molecular characterization of copper resistance genes from Xanthomonas citri subsp. citri and Xanthomonas alfalfae subsp. citrumelonis. Appl. Environ. Microbiol. 2011, 77, 4089–4096. [Google Scholar] [CrossRef] [Green Version]
  9. Hyun, J.W.; Kim, H.J.; Yi, P.H.; Hwang, R.Y.; Park, E.W. Mode of action of streptomycin resistance in the citrus canker pathogen (Xanthomonas smithii subsp. citri) in Jeju island. Plant Pathol. J. 2012, 28, 207–211. [Google Scholar] [CrossRef] [Green Version]
  10. Klein-Gordon, J.M.; Xing, Y.; Garrett, K.A.; Abrahamian, P.; Paret, M.L.; Minsavage, G.V.; Strayer-Scherer, A.L.; Fulton, J.C.; Timilsina, S.; Jones, J.B.; et al. Assessing changes and associations in the Xanthomonas perforans population across Florida commercial tomato fields via a statewide survey. Phytopathology 2021, 111, 1029–1041. [Google Scholar] [CrossRef]
  11. Köhl, J.; Kolnaar, R.; Ravensberg, W.J. Mode of action of microbial biological control agents against plant diseases: Relevance beyond efficacy. Front. Plant Sci. 2019, 10, 845. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Pham, J.V.; Yilma, M.A.; Feliz, A.; Majid, M.T.; Maffetone, N.; Walker, J.R.; Kim, E.; Cho, H.J.; Reynolds, J.M.; Song, M.C.; et al. A review of the microbial production of bioactive natural products and biologics. Front. Microbiol. 2019, 10, 1404. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Rabbee, M.F.; Baek, K.H. Antimicrobial activities of lipopeptides and polyketides of Bacillus velezensis for agricultural applications. Molecules 2020, 25, 4973. [Google Scholar] [CrossRef] [PubMed]
  14. Kunst, F.; Ogasawara, N.; Moszer, I.; Albertini, A.M.; Alloni, G.O.; Azevedo, V.; Bertero, M.G.; Bessières, P.; Bolotin, A.; Borchert, S.; et al. The complete genome sequence of the Gram-positive bacterium Bacillus subtilis. Nature 1997, 390, 249–256. [Google Scholar] [CrossRef] [Green Version]
  15. Zaid, D.S.; Cai, S.; Hu, C.; Li, Z.; Li, Y.; Gralnick, J.A. Comparative genome analysis reveals phylogenetic identity of Bacillus velezensis HNA3 and genomic insights into its plant growth promotion and biocontrol effects. Microbiol. Spectr. 2022, 10, e02169-21. [Google Scholar] [CrossRef]
  16. Chu, D.; Ilyas, N.; Peng, L.; Wang, X.; Wang, D.; Xu, Z.; Gao, Q.; Tan, X.; Zhang, C.; Li, Y.; et al. Genomic insights on fighting bacterial wilt by a novel Bacillus amyloliquefaciens strain Cas02. Microb. Biotechnol. 2022, 15, 1152–1167. [Google Scholar] [CrossRef]
  17. Xu, B.H.; Lu, Y.Q.; Ye, Z.W.; Zheng, Q.W.; Wei, T.; Lin, J.F.; Guo, L.Q. Genomics-guided discovery and structure identification of cyclic lipopeptides from the Bacillus siamensis JFL15. PLoS ONE 2018, 13, e0202893. [Google Scholar] [CrossRef]
  18. Rabbee, M.F.; Ali, M.S.; Choi, J.; Hwang, B.S.; Jeong, S.C.; Baek, K. Bacillus velezensis: A Valuable member of bioactive molecules within plant microbiomes. Molecules 2019, 24, 1046. [Google Scholar] [CrossRef] [Green Version]
  19. Pfeifer, B.A.; Khosla, C. Biosynthesis of polyketides in heterologous hosts. Microbiol. Mol. Biol. Rev. 2001, 65, 106–118. [Google Scholar] [CrossRef] [Green Version]
  20. Ongena, M.; Jacques, P. Bacillus lipopeptides: Versatile weapons for plant disease biocontrol. Trends Microbiol. 2007, 16, 115–125. [Google Scholar] [CrossRef]
  21. Chen, X.H.; Koumoutsi, A.; Scholz, R.; Eisenreich, A.; Schneider, K.; Heinemeyer, I.; Morgenstern, B.; Voss, B.; Hess, W.R.; Reva, O.; et al. Comparative analysis of the complete genome sequence of the plant growth–promoting bacterium Bacillus amyloliquefaciens FZB42. Nat. Biotechnol. 2007, 25, 1007–1014. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Zhang, L.; Sun, C. Fengycins, cyclic lipopeptides from marine Bacillus subtilis strains, kill the plant-pathogenic fungus Magnaporthe grisea by Inducing reactive oxygen species production and chromatin condensation. Appl. Environ. Microbiol. 2018, 84, e00445-18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Li, P.; Chen, M.; Tang, W.; Guo, Z.; Zhang, Y.; Wang, M.; Horsman, G.P.; Zhong, J.; Lu, Z.; Chen, Y. Initiating polyketide biosynthesis by on-line methyl esterification. Nat. Commun. 2021, 12, 4499. [Google Scholar] [CrossRef]
  24. Gu, Q.; Yang, Y.; Yuan, Q.; Shi, G.; Wu, L.; Lou, Z.; Huo, R.; Wu, H.; Rainer Borriss, X.G. Bacillomycin D produced by Bacillus amyloliquefaciens is involved in the antagonistic interaction with the plant-pathogenic fungus Fusarium graminearum. Appl. Environ. Microbiol 2017, 83, e01075-17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Moreno-Velandia, C.A.; Ongena, M.C.A. Effects of Fengycins and iturins on Fusarium oxysporum f. sp. physali and root colonization by Bacillus velezensis Bs006 protect golden berry against vascular wilt. Phytopathology 2021, 111, 2227–2237. [Google Scholar] [CrossRef]
  26. Grady, E.N.; MacDonald, J.; Ho, M.T.; Weselowski, B.; McDowell, T.; Solomon, O.; Renaud, J.; Yuan, Z.C. Characterization and complete genome analysis of the surfactin-producing, plant-protecting bacterium Bacillus velezensis 9D-6. BMC Microbiol. 2019, 19, 5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Chen, L.; Heng, J.; Qin, S.; Bian, K. A comprehensive understanding of the biocontrol potential of Bacillus velezensis LM2303 against Fusarium head blight. PLoS ONE 2018, 13, e0198560. [Google Scholar] [CrossRef] [Green Version]
  28. Chen, X.-H.; Vater, J.; Piel, J.; Franke, P.; Scholz, R.; Schneider, K.; Koumoutsi, A.; Hitzeroth, G.; Grammel, N.; Strittmatter, A.W.; et al. Structural and functional characterization of three polyketide synthase gene clusters in Bacillus amyloliquefaciens FZB 42. J. Bacteriol. 2006, 188, 4024–4036. [Google Scholar] [CrossRef] [Green Version]
  29. Wu, L.; Wu, H.; Chen, L.; Yu, X.; Borriss, R.; Gao, X. Difficidin and bacilysin from Bacillus amyloliquefaciens FZB42 have antibacterial activity against Xanthomonas oryzae rice pathogens. Sci. Rep. 2015, 5, 12975. [Google Scholar] [CrossRef] [Green Version]
  30. Han, X.; Shen, D.; Xiong, Q.; Bao, B.; Zhang, W.; Dai, T.; Zhao, Y.; Borriss, R.; Fan, B. The plant-beneficial rhizobacterium Bacillus velezensis FZB42 controls the soybean pathogen Phytophthora sojae due to bacilysin production. Appl. Environ. Microbiol. 2021, 87, e01601-21. [Google Scholar] [CrossRef]
  31. Kalyon, B.; Helaly, S.E.; Scholz, R.; Nachtigall, J.; Vater, J.; Borriss, R.; Süssmuth, R.D. Plantazolicin A and B: Structure elucidation of ribosomally synthesized thiazole/oxazole peptides from Bacillus amyloliquefaciens FZB42. Org. Lett. 2011, 13, 2996–2999. [Google Scholar] [CrossRef] [PubMed]
  32. Scholz, R.; Vater, J.; Budiharjo, A.; Wang, Z.; He, Y.; Dietel, K.; Schwecke, T.; Herfort, S.; Lasch, P.; Borriss, R. Amylocyclicin, a novel circular bacteriocin produced by Bacillus amyloliquefaciens FZB42. J. Bacteriol. 2014, 196, 1842–1852. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Skaar, E.P. The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog. 2010, 6, e1000949. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Rabbee, M.F.; Islam, N.; Baek, K.H. Biocontrol of citrus bacterial canker caused by Xanthomonas citri subsp. citri by Bacillus velezensis. Saudi J. Biol. Sci. 2022, 29, 2363–2371. [Google Scholar] [CrossRef] [PubMed]
  35. Rabbee, M.F.; Ali, S.; Baek, K. Endophyte Bacillus velezensis isolated from citrus spp. controls streptomycin-resistant Xanthomonas citri subsp. citri that causes citrus bacterial canker. Agronomy 2019, 9, 470. [Google Scholar] [CrossRef] [Green Version]
  36. Qureshi, K.A.; Bholay, A.D.; Rai, P.K.; Mohammed, H.A. Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin X2 and actinomycin D produced by novel Streptomyces smyrnaeus UKAQ_23. Sci. Rep. 2021, 11, 14539. [Google Scholar] [CrossRef]
  37. Zhi, Y.; Wu, Q.; Xu, Y. Genome and transcriptome analysis of surfactin biosynthesis in Bacillus amyloliquefaciens MT45. Sci. Rep. 2017, 7, 40976. [Google Scholar] [CrossRef] [Green Version]
  38. Cho, M.S.; Jin, Y.J.; Kang, B.K.; Park, Y.K.; Kim, C.; Park, D.S. Understanding the ontogeny and succession of Bacillus velezensis and B. subtilis subsp. subtilis by focusing on kimchi fermentation. Sci. Rep. 2018, 8, 7045. [Google Scholar] [CrossRef] [Green Version]
  39. Cao, Y.; Pi, H.; Chandrangsu, P.; Li, Y.; Wang, Y.; Zhou, H.; Xiong, H.; Helmann, J.D.; Cai, Y. Antagonism of two plant-growth promoting Bacillus velezensis isolates against Ralstonia solanacearum and Fusarium oxysporum. Sci. Rep. 2018, 8, 4360. [Google Scholar] [CrossRef] [Green Version]
  40. Chowdhury, S.P.; Uhl, J.; Grosch, R.; Alquéres, S.; Pittroff, S.; Dietel, K.; Schmitt-Kopplin, P.; Borriss, R.; Hartmann, A. Cyclic lipopeptides of Bacillus amyloliquefaciens subsp. plantarum colonizing the lettuce rhizosphere enhance plant defense responses toward the bottom rot pathogen Rhizoctonia solani. Mol. Plant-Microbe Interact. 2015, 28, 984–995. [Google Scholar] [CrossRef] [Green Version]
  41. Zeriouh, H.; Romero, D.; García-Gutiérrez, L.; Cazorla, F.M.; De Vicente, A.; Pérez-García, A. The iturin-like lipopeptides are essential components in the biological control arsenal of Bacillus subtilis against bacterial diseases of cucurbits. Mol. Plant-Microbe Interact. 2011, 24, 1540–1552. [Google Scholar] [CrossRef] [Green Version]
  42. Hynek, M.; Marešov, H.; Ju, T. Killing Effect of Bacillus velezensis FZB42 on a Xanthomonas campestris pv. campestris (Xcc) strain newly isolated from cabbage Brassica oleracea Convar. Capitata (L.): A Metabolomic Study. Microorganisms 2021, 9, 1410. [Google Scholar]
  43. Wang, T.; Liu, X.H.; Wu, M.B.; Ge, S. Molecular insights into the antifungal mechanism of bacilysin. J. Mol. Model. 2018, 24, 118. [Google Scholar] [CrossRef] [PubMed]
  44. Gong, A.D.; Li, H.P.; Yuan, Q.S.; Song, X.S.; Yao, W.; He, W.J.; Zhang, J.B.; Liao, Y.C. Antagonistic mechanism of iturin a and plipastatin a from Bacillus amyloliquefaciens S76-3 from wheat spikes against Fusarium graminearum. PLoS ONE 2015, 10, e0116871. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Duitman, E.H.; Hamoen, L.W.; Rembold, M.; Venema, G.; Seitz, H.; Saenger, W.; Bernhard, F.; Reinhardt, R.; Schmidt, M.; Ullrich, C.; et al. The mycosubtilin synthetase of Bacillus subtilis ATCC6633: A multifunctional hybrid between a peptide synthetase, an amino transferase, and a fatty acid synthase. Proc. Natl. Acad. Sci. USA 1999, 96, 13294–13299. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Fan, H.; Zhang, Z.; Li, Y.; Zhang, X.; Duan, Y.; Wang, Q. Biocontrol of bacterial fruit blotch by Bacillus subtilis 9407 via surfactin-mediated antibacterial activity and colonization. Front. Microbiol. 2017, 8, 1973. [Google Scholar] [CrossRef]
Figure 1. Antibacterial effect of the metabolic extract of B. velezensis Bv-25 against X. citri subsp. citri using the culture broth of Landy broth and YNB. (a) bactericidal activity was conducted against the wild-type X. citri subsp. citri (XccW1); (b) bactericidal activity was conducted against the streptomycin resistant X. citri subsp. citri (XccM4); C: methanol; S1: streptomycin (1.0 mg mL−1); S2: streptomycin (0.1 mg mL−1). (c) measurement of inhibition zones (mm) of ethyl acetate extracts of Bv-25 against XccW1; (d) measurement of inhibition zones (mm) of ethyl acetate extracts of Bv-25 against XccM4.
Figure 1. Antibacterial effect of the metabolic extract of B. velezensis Bv-25 against X. citri subsp. citri using the culture broth of Landy broth and YNB. (a) bactericidal activity was conducted against the wild-type X. citri subsp. citri (XccW1); (b) bactericidal activity was conducted against the streptomycin resistant X. citri subsp. citri (XccM4); C: methanol; S1: streptomycin (1.0 mg mL−1); S2: streptomycin (0.1 mg mL−1). (c) measurement of inhibition zones (mm) of ethyl acetate extracts of Bv-25 against XccW1; (d) measurement of inhibition zones (mm) of ethyl acetate extracts of Bv-25 against XccM4.
Microorganisms 11 01523 g001
Figure 2. mRNA expression analysis of the biosynthetic gene clusters encoding the antimicrobial compounds of Bv-25. The relative FPKM expression level was exhibited as log2 fold change (log2 FC). FPKM (fragments per kilobase of exon model per million mapped reads).
Figure 2. mRNA expression analysis of the biosynthetic gene clusters encoding the antimicrobial compounds of Bv-25. The relative FPKM expression level was exhibited as log2 fold change (log2 FC). FPKM (fragments per kilobase of exon model per million mapped reads).
Microorganisms 11 01523 g002
Table 1. Determination of the MIC and MBC of the metabolic extract of B. velezensis Bv-25 against wild type XccW1 and streptomycin resistant XccM4 using the culture broth of Landy and YNB.
Table 1. Determination of the MIC and MBC of the metabolic extract of B. velezensis Bv-25 against wild type XccW1 and streptomycin resistant XccM4 using the culture broth of Landy and YNB.
Xcc StrainsExtract of Bv-25 Using Landy BrothExtract of Bv-25 Using YNBStreptomycin
MIC (µg mL−1)MBC (µg mL−1)MIC (µg mL−1)MBC (µg mL−1)MIC (µg mL−1)MBC (µg mL−1)
XccW131.2562.562.5125.01.252.5
XccM431.2562.562.5125.0>500>1000
Table 2. Cyclic lipopeptide and polyketide molecules produced by the B. velezensis Bv-25 strain as detected by HPLC-MS analysis. The values of Ba-2 and Bv-25 were the means of the data from three independent replications.
Table 2. Cyclic lipopeptide and polyketide molecules produced by the B. velezensis Bv-25 strain as detected by HPLC-MS analysis. The values of Ba-2 and Bv-25 were the means of the data from three independent replications.
Compound NameM/ZRT (min)Ba-2Bv-25Fold Change
(Bv-25/Ba-2)
p-Value
Oxydifficidin559.043.3216,380.330,417,069.1140.60.0027
Bacillaene582.231.3291,622.72,774,552.59.50.0001
Macrolactin524.238.6308,031.12,211,408.97.20.0046
Surfactin1036.627.093,166.21,420,585.515.20.0000
Fengycin A1475.930.5128,474.21,092,443.58.50.0006
Fengycin B1489.331.3158,266.9983,475.36.20.0005
Bacillomycin D1118.640.592,804.419,132,037.6206.20.0031
Iturin1083.729.3272,286.62,513,178.39.20.0036
Table 3. Genes associated with the antibacterial compounds of B. velezensis Bv-25 during mRNA expression analysis.
Table 3. Genes associated with the antibacterial compounds of B. velezensis Bv-25 during mRNA expression analysis.
Active
Compound
GeneUniProt IDProduct
BacilysinbacAQ8KWT6Prephenate decarboxylase
bacBQ8KWT53-[(4R)-4-hydroxycyclohexa-1,5-dien-1-yl]-2-oxopropanoate isomerase
bacCQ8KWT4Dihydroanticapsin dehydrogenase
bacDQ8KWT3L-alanine-anticapsin ligase
bacEQ8KWT2Putative bacilysin exporter
ywfGP39643Probable aspartate aminotransferase
ywfHP39644Bacilysin biosynthesis oxidoreductase
Plipastatin or
Fengycin
ppsAP39845Plipastatin synthase subunit A
ppsBP39846Plipastatin synthase subunit B
ppsCP39847Plipastatin synthase subunit C
ppsDP94459Plipastatin synthase subunit D
ppsEO31827Plipastatin synthase subunit E
MycosubtilinfenFQ9R9J2Malonyl CoA-acyl carrier protein transacylase
mycAQ9R9J1Mycosubtilin synthase subunit A
mycBQ9R9J0Mycosubtilin synthase subunit B
mycCQ9R9I9Mycosubtilin synthase subunit C
SurfactinsrfADQ08788Surfactin synthase thioesterase subunit
srfACQ08787Surfactin synthase subunit 3
srfABQ04747Surfactin synthase subunit 2
srfAAP27206Surfactin synthase subunit 1
Table 4. Genes associated with the bacterium-plant interactions during mRNA expression analysis of B. velezensis Bv-25.
Table 4. Genes associated with the bacterium-plant interactions during mRNA expression analysis of B. velezensis Bv-25.
BioactivityGeneProductLog2 FC
Biofilm formation (Exopolysaccharide component)epsCProbable polysaccharide biosynthesis protein−3.17
epsDPutative glycosyltransferase−2.08
epsEPutative glycosyltransferase−4.00
epsFPutative glycosyltransferase−0.45
epsGTransmembrane protein0.04
epsHPutative glycosyltransferase−1.25
epsIPutative pyruvyl transferase−0.85
epsJUncharacterized glycosyltransferase0.51
epsKUncharacterized membrane protein0.20
epsLUncharacterized sugar transferase−0.88
epsMPutative acetyltransferase EpsM−1.37
epsNPutative pyridoxal phosphate-dependent aminotransferase−0.55
Plant growth promotion and ISR induction
(3- hydroxy-2-butanone)
alsRHTH-type transcriptional regulator2.77
alsSAcetolactate synthase−3.58
alsDAlpha-acetolactate decarboxylase−7.67
Plant growth promotion
(Indole acetic acid)
ysnEUncharacterized N-acetyltransferaseinf
yhcXHydrolase−0.48
Plant growth promotion
(Trehalose)
treRTrehalose operon transcriptional repressor1.91
treATrehalose-6-phosphate hydrolase1.32
trePPTS system trehalose-specific EIIBC component0.72
Table 5. Expression of key genes of B. velezensis Bv-25 related to ion assimilation during mRNA expression analysis.
Table 5. Expression of key genes of B. velezensis Bv-25 related to ion assimilation during mRNA expression analysis.
BioactivityGeneProductLog2 FC
Bacillibactin for iron
(Fe2+) assimilation
dhbA2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase0.80
dhbCIsochorismate synthase−1.52
dhbE2,3-dihydroxybenzoate-AMP ligase−2.45
dhbBIsochorismatase−3.08
dhbFDimodular nonribosomal peptide synthase−1.32
Manganese
(Mn2+) assimilation
mntHDivalent metal cation transporter3.71
mntPPutative manganese efflux pump0.69
mntRTranscriptional regulator−0.75
Magnesium (Mg2+) assimilationmgtEMagnesium transporter2.19
corAMagnesium transport protein−2.66
Potassium (K) assimilationktrDKtr system potassium uptake protein D1.06
ktrCKtr system potassium uptake protein C−2.75
Nitrogen (N) assimilationmoaACyclic pyranopterin monophosphate synthase−1.03
moaBMolybdenum cofactor biosynthesis protein B1.59
moaCCyclic pyranopterin monophosphate synthase0.79
moaDMolybdopterin synthase sulfur carrier subunit0.00
nasBAssimilatory nitrate reductase electron transfer subunit1.34
nasDNitrite reductase [NAD(P)H]2.82
nasFUroporphyrinogen-III C-methyltransferase0.41
nrgBNitrogen regulatory PII-like protein−3.03
narKNitrite extrusion protein3.04
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rabbee, M.F.; Baek, K.-H. Detection of Antagonistic Compounds Synthesized by Bacillus velezensis against Xanthomonas citri subsp. citri by Metabolome and RNA Sequencing. Microorganisms 2023, 11, 1523. https://doi.org/10.3390/microorganisms11061523

AMA Style

Rabbee MF, Baek K-H. Detection of Antagonistic Compounds Synthesized by Bacillus velezensis against Xanthomonas citri subsp. citri by Metabolome and RNA Sequencing. Microorganisms. 2023; 11(6):1523. https://doi.org/10.3390/microorganisms11061523

Chicago/Turabian Style

Rabbee, Muhammad Fazle, and Kwang-Hyun Baek. 2023. "Detection of Antagonistic Compounds Synthesized by Bacillus velezensis against Xanthomonas citri subsp. citri by Metabolome and RNA Sequencing" Microorganisms 11, no. 6: 1523. https://doi.org/10.3390/microorganisms11061523

APA Style

Rabbee, M. F., & Baek, K.-H. (2023). Detection of Antagonistic Compounds Synthesized by Bacillus velezensis against Xanthomonas citri subsp. citri by Metabolome and RNA Sequencing. Microorganisms, 11(6), 1523. https://doi.org/10.3390/microorganisms11061523

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop